About this trial
The population included in this study consists of tracheostomy patients admitted to the pulmonary department of Beijing Rehabilitation Hospital, undergoing decannulation rehabilitation treatment. Once patient conditions stabilized, they were all transitioned to the decannulation process established by our department in 2018, which utilizes a speaking valve instead of capping. Each enrolled patient received physiological monitoring upon admission and the day prior to the initial use of the speaking valve, with continuous monitoring for 24 hours through wearable devices.The monitored physiological parameters were compared between the successful decannulation group and the failed decannulation group, and a predictive decannulation model was established in advance based on clinical parameters.
Decannulation criteria: If the patient can tolerate wearing the speaking valve continuously for 4 hours (gradually increasing the duration: 30 minutes, 1 hour, 2 hours, 4 hours), and if PEF \> 100 liters/min, planned removal of the tracheostomy tube can be considered.
Based on decannulation outcomes, patients were categorized into the successful decannulation group and the failed decannulation group.
Successful decannulation group: Patients who successfully completed the decannulation process and had their tubes removed, with no reinsertion of the tracheostomy tube or endotracheal intubation within 48 hours after decannulation.
Failed decannulation group: Patients who did not pass the decannulation process, and the multidisciplinary team advised against removal of the tracheostomy tube; or patients who passed the decannulation process and had the tracheostomy tube removed but required reinsertion of the tracheostomy tube or endotracheal intubation within 48 hours due to medical conditions.
Eligibility criteria
Qualifiers
18 years ≤ Age ≤ 90 years, non-mechanically ventilated patients.
Tracheotomy completed, ≥48 hours since cannula placement (postoperative early edema has stabilized).
Patient or legal representative has provided informed consent.
Disqualifiers
Recent (≤48 hours) major neck/upper airway surgery requiring avoidance of upper airway airflow impact.
Severe consciousness disorder/delirium (RASS ≤ -3 or ≥ +2), extreme anxiety/inability to cooperate.
Total laryngectomy or laryngo-tracheal separation.
Oral endotracheal intubation.
Trial design
Treatments tested in this trial
- Successful decannulation group
- Failed decannulation group
Treatment groups
Locations
Sponsors and collaborators
Bin Zhang
Lead sponsor
Capital Medical University
Sponsor institution
Beijing Rehabilitation Hospital
Collaborator
Chinese PLA General Hospital
Collaborator